Cargando…

Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma

Reactivation of hepatitis B virus (HBV) is a well-known complication in patients with hematological malignancies during or after cytotoxic chemotherapy. If the initiation of antiviral therapy is delayed in patients with HBV reactivation, these patients can develop severe hepatitis and may die of ful...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsukune, Yutaka, Sasaki, Makoto, Komatsu, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895787/ https://www.ncbi.nlm.nih.gov/pubmed/31752356 http://dx.doi.org/10.3390/cancers11111819

Ejemplares similares

Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan
por: Tsukune, Yutaka, et al.
Publicado: (2017)

Improvement in the Symptoms and VEGF Levels after Resection of an Extrame Dullary Spinal Tumor and Additional Chemotherapy in a Patient with Multiple Myeloma Complicated with POEMS Syndrome
por: Sano, Mariko, et al.
Publicado: (2021)

Clinical impact of serum soluble SLAMF7 in multiple myeloma
por: Ishibashi, Mariko, et al.
Publicado: (2018)

Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy
por: Kikuchi, Takaki, et al.
Publicado: (2020)

Management of Multiple Myeloma Complicated by Hepatitis C Virus Reactivation: The Role of New Antiviral Therapy
por: Mahale, Parag, et al.
Publicado: (2015)

Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab Vedotin
por: Uchimura, Ayana, et al.
Publicado: (2022)

Hepatitis B Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Regimens Containing Lenalidomide and/or Bortezomib
por: Ataca Atilla, Pınar, et al.
Publicado: (2019)

Reactivation of hepatitis B virus infection in patients with hematologic disorders
por: Wang, Bo, et al.
Publicado: (2019)

Abnormal Exacerbation of Moderately Differentiated Gastric Adenocarcinoma in a Patient with TAFRO Syndrome: An Impaired Tumor Immunity?
por: Inano, Tadaaki, et al.
Publicado: (2022)

Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)
por: Pisaturo, Mariantonietta, et al.
Publicado: (2019)

Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma
por: Yasuda, Hajime, et al.
Publicado: (2020)

Oncolytic Viruses for Multiple Myeloma Therapy
por: Calton, Christine M., et al.
Publicado: (2018)

Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes
por: Teng, Chung-Jen, et al.
Publicado: (2011)

Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus
por: Han, Lu, et al.
Publicado: (2020)

Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention
por: Sagnelli, Caterina, et al.
Publicado: (2019)

Potential of oncolytic viruses in the treatment of multiple myeloma
por: Bartee, Eric
Publicado: (2018)

The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma
por: Stewart, Georgia, et al.
Publicado: (2021)

Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era
por: Mak, Joyce Wing Yan, et al.
Publicado: (2023)

Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis
por: Inada, Kento, et al.
Publicado: (2021)

Management of hepatitis B virus reactivation due to treatment of COVID-19
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2022)

Hepatitis B virus reactivation in rheumatoid arthritis
por: Wu, Ya-Li, et al.
Publicado: (2022)

Roles of Hepatitis B Virus Mutations in the Viral Reactivation after Immunosuppression Therapies
por: Inoue, Jun, et al.
Publicado: (2019)

New Markers in Monitoring the Reactivation of Hepatitis B Virus Infection in Immunocompromised Hosts
por: Svicher, Valentina, et al.
Publicado: (2019)

Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma
por: Hannaford, Alisse, et al.
Publicado: (2017)

Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy
por: Lam, Lok-Ka, et al.
Publicado: (2023)

Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
por: Pawłowska, Małgorzata, et al.
Publicado: (2019)

Extramedullary Multiple Myeloma with Hepatic Involvement
por: Singh, Manpreet, et al.
Publicado: (2021)

Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs
por: Kim, Doh Hyung, et al.
Publicado: (2018)

Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis
por: Ciardi, Maria R, et al.
Publicado: (2018)

Immune-Escape Hepatitis B Virus Mutations Associated with Viral Reactivation upon Immunosuppression
por: Lazarevic, Ivana, et al.
Publicado: (2019)

Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases
por: Onorato, Lorenzo, et al.
Publicado: (2021)

Multiple myeloma
por: Collins, Conor D.
Publicado: (2010)

The NF-κB Activating Pathways in Multiple Myeloma
por: Roy, Payel, et al.
Publicado: (2018)

Targeting NF-κB Signaling for Multiple Myeloma
por: Wong, Ada Hang-Heng, et al.
Publicado: (2020)

The Multiple Facets and Disorders of B Cell Functions in Hepatitis B Virus Infection
por: Ablikim, Dilhumare, et al.
Publicado: (2023)

Hepatitis B and Hepatitis C Reactivation in the Biologic Era
por: Bojito-Marrero, Lizza, et al.
Publicado: (2014)

Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels <500 copies/mL
por: Xie, Zhi-Bo, et al.
Publicado: (2016)

Hepatitis B Virus Reactivation under Treatment with Nilotinib
por: Temel, Tuncer, et al.
Publicado: (2015)

Hepatitis B Virus Reactivation Associated With Therapeutic Interventions
por: Chang, Young, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qoin55rkb61iah9tule6562kuo